Cointime

  • Haberler
  • Haber
  • Para Birimi
  • Köşe Yazısı
  • Etkinlik
  • Bitcoin $79,702.24 -0.02%
  • Ethereum $2,481.17 +0.91%
  • BNB $745.07 -2.81%
  • Optimism $0.11 +8.41%
  • Arbitrum $0.19 +40.87%
  • Solana $105.84 +3.02%
  • Polygon $0.22 +2.77%
  • Cosmos $1.58 +1.90%
  • Avalanche $7.62 +1.00%
  • Bitcoin $79,702.24 -0.02%
  • Ethereum $2,481.17 +0.91%
  • BNB $745.07 -2.81%
  • Optimism $0.11 +8.41%
  • Arbitrum $0.19 +40.87%
  • Solana $105.84 +3.02%
  • Polygon $0.22 +2.77%
  • Cosmos $1.58 +1.90%
  • Avalanche $7.62 +1.00%
Home / Karyopharm Therapeutics / investors

Karyopharm Therapeutics

company

Investors

Number of Lead Investors
Number of Investors
5
14
Karyopharm Therapeutics is funded by 14 investors. Avidity Partners and Foresite Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Avidity Partners Yes Post-IPO Equity
Foresite Capital Yes Series B
Chione Yes Series A
Multiple Myeloma Research Foundation Yes Grant
Adage Capital Management - Post-IPO Equity
Armistice Capital - Post-IPO Equity
HealthCor Partners - Post-IPO Equity
Heights Capital Management - Post-IPO Equity
Marshall Wace - Post-IPO Equity
Rubric Capital Management - Post-IPO Equity
SilverArc Capital - Post-IPO Equity
Surveyor Capital - Post-IPO Equity
Delphi Ventures - Series B
New Leaf Venture Partners - Series B

Contact

Newton,Massachusetts,United States
+1 617 658 0600
Cointime
İçerikler
  • Haberler
  • Girişimler
  • Araştırmalar
  • Teknoloji
  • Etkinlik
Şirket.
  • Hakkımızda
  • Reklam İşbirliği
  • Sorumluluk Reddi
  • © 2023 Cointime. Tüm Hakları Saklıdır
  • Gizlilik Politikası
  • Hizmet Şartları